Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.03
+0.08001.15%
Post-market: 7.030.00000.00%19:30 EDT
Volume:176.63K
Turnover:1.24M
Market Cap:245.42M
PE:7.34
High:7.06
Open:7.05
Low:6.96
Close:6.95
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.20M
Volume Ratio:1.12
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.07
PE(LYR):7.32

Loading ...

Tredegar Corp: Are Optimizing Billet Casting Operations at Our Carthage, Tn, and Newnan, Ga Facilities to Overcome Localized Production Constraints.

THOMSON REUTERS
·
May 08

Tredegar: Through Q3 2026, Transitioned Nearly All of Aluminum Supply Previously Sourced From Middle East to North American Partners

THOMSON REUTERS
·
May 08

Tredegar Q1 Net Income From Cont Ops USD 5 Million

THOMSON REUTERS
·
May 08

Tredegar Q1 Adjusted EPS USD 0.15

THOMSON REUTERS
·
May 08

Tredegar Corp: Tariffs and Duties Continue to Be Passed Through to Customers Under Company's Metal‑Cost Adjustment Mechanism

THOMSON REUTERS
·
May 08

TG Therapeutics (TGTX) Q1 2026 Results Put 66% Net Margin Narrative To The Test

Simply Wall St.
·
May 08

TG Therapeutics price target raised to $70 from $60 at H.C. Wainwright

TIPRANKS
·
May 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX) and Insulet (PODD)

TIPRANKS
·
May 07

TG Therapeutics Up Over 14%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk

Dow Jones
·
May 07

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

TG Therapeutics Q1 Adj. EPS $0.18 Misses $0.30 Estimate, Sales $204.918M Beat $196.814M Estimate

Benzinga Earnings
·
May 06

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.12, vs. FactSet Est of $0.28

MT Newswires Live
·
May 06

TG-17 Reshapes Capital Structure with New Financing Terms

TIPRANKS
·
May 04

Amarin Reports 2026 First Quarter Financial Results

GlobeNewswire
·
Apr 29

TG Metals boosts Van Uden gold resource and advances lithium processing technology

TIPRANKS
·
Apr 28

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

TG Metals details advanced WA gold and lithium projects and data caveats

TIPRANKS
·
Apr 20

TG Metals to Release 5.7 Million Shares From Escrow in April 2026

TIPRANKS
·
Apr 17

Goldman Sachs Reaffirms Their Hold Rating on TG Therapeutics (TGTX)

TIPRANKS
·
Apr 16

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction

GlobeNewswire
·
Apr 08